These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25894010)

  • 1. World Health Organization essential medicines lists: where are the drugs to treat neuropathic pain?
    Kamerman PR; Wadley AL; Davis KD; Hietaharju A; Jain P; Kopf A; Meyer AC; Raja SN; Rice ASC; Smith BH; Treede RD; Wiffen PJ
    Pain; 2015 May; 156(5):793-797. PubMed ID: 25894010
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved neuropathic pain treatment in developing countries--a critical review of WHO essential list.
    Soyannwo OA
    Pain; 2015 May; 156(5):763-764. PubMed ID: 25719619
    [No Abstract]   [Full Text] [Related]  

  • 3. The selection and use of essential medicines.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (985):i-xiv, 1-219, back cover. PubMed ID: 25080778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selection and use of essential medicines.
    World Health Organization
    World Health Organ Tech Rep Ser; 2011; (965):i-xiv, 1-249. PubMed ID: 22891532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
    Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
    Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2007; (946):1-162, back cover. PubMed ID: 18309920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO Essential Medicines Committee spotlights unaffordable drugs.
    Furlow B
    Lancet Oncol; 2021 Nov; 22(11):1503. PubMed ID: 34627500
    [No Abstract]   [Full Text] [Related]  

  • 8. Adding a medicine to the WHO model list of essential medicines.
    Kishore SP; Herbstman BJ
    Clin Pharmacol Ther; 2009 Mar; 85(3):237-9. PubMed ID: 19223877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Association for Hospice and Palliative Care list of essential medicines for palliative care.
    De Lima L; Doyle D
    J Pain Palliat Care Pharmacother; 2007; 21(3):29-36. PubMed ID: 18032353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making the list: the role of essential medicines lists in reproductive health.
    Hutchings J; Neroutsos K; Donnelly K
    Int Perspect Sex Reprod Health; 2010 Dec; 36(4):205-8. PubMed ID: 21245027
    [No Abstract]   [Full Text] [Related]  

  • 11. What has been the impact of the concept of essential drugs?
    Levy M; Reidenberg MM
    Clin Pharmacol Ther; 2003 Apr; 73(4):275-8. PubMed ID: 12709716
    [No Abstract]   [Full Text] [Related]  

  • 12. The Selection and Use of Essential Medicines.
    World Health Organ Tech Rep Ser; 2015; (994):vii-xv, 1-546. PubMed ID: 27183787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines).
    World Health Organ Tech Rep Ser; 2003; 914():i-vi, 1-126. PubMed ID: 12872478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential Medicines in National Constitutions: Progress Since 2008.
    Katrina Perehudoff S; Toebes B; Hogerzeil H
    Health Hum Rights; 2016 Jun; 18(1):141-156. PubMed ID: 27781006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On WHO's essential medicines process and transparency.
    Magrini N; Robertson J; de Joncheere K; Bero L
    BMJ; 2014 Sep; 349():g5637. PubMed ID: 25231094
    [No Abstract]   [Full Text] [Related]  

  • 16. Global aspects of drug development.
    Hoppu K; Hogerzeil HV
    Handb Exp Pharmacol; 2011; 205():353-72. PubMed ID: 21882121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
    Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
    J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The composition of WHO's expert committee on essential medicines needs more scrutiny.
    Welch C
    BMJ; 2014 Aug; 349():g5211. PubMed ID: 25138008
    [No Abstract]   [Full Text] [Related]  

  • 19. Setting standards for essential children's medicines.
    Hill SR; Gray A; Weber M
    Bull World Health Organ; 2007 Sep; 85(9):650. PubMed ID: 18026613
    [No Abstract]   [Full Text] [Related]  

  • 20. Decisions on WHO's essential medicines need more scrutiny.
    Barbui C; Purgato M
    BMJ; 2014 Jul; 349():g4798. PubMed ID: 25081250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.